Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validating the Ability for Early Recognition of Worsening Heart Failure by a System Technology of Automated Prediction From Multi-sensor Data: A Prospective, Open-label, Single-arm, International, Multi-center Clinical Study

NCT04758429 is registered in ClinicalTrials.gov with Chronolife as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04758429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validating the Ability for Early Recognition of Worsening Heart Failure by a System Technology of Automated Prediction From Multi-sensor Data: A Prospective, Open-label, Single-arm, International, Multi-center Clinical Study
Lead sponsor
Chronolife
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2021
Completion date
May 31, 2022
Enrollment
552 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure